Sanofi and GlaxoSmithKline are restarting clinical development of their COVID-19 vaccine, which was delayed after hitting a snag late last year. In December interim phase 1/2 trial results showed ...

In pediatric patients aged 6 months to 5 years, the VE of mRNA-1273 against symptomatic infection was modest after a single dose and strong after a second dose.

Electronic reminders to encourage older adults in Denmark to get vaccinated against flu may have unintentionally lowered ...

Researchers have discovered that mRNA-based COVID-19 vaccines have a persistent effect on the innate immune system. These mechanisms may help the human body to better protect itself against potential ...

As it returns from the brink, the vaccine developer has brought in Dr. Ruxandra Draghia-Akli — and her industry and public health chops — to lead R&D.

This decision underscores the need for a preventative measure against the chlamydia, which affects millions worldwide.

The Gaithersburg biotech is two years into its second transformation in five years, a return to its roots as a scientific engine, after advancing a Covid-19 vaccine to market through the pandemic ...

Rep. Marjorie Taylor Greene, R-Ga., declared that U.S. Food and Drug Administration approval for COVID-19 vaccines should be yanked, asserting that the jabs "are causing permanent harm and deaths." ...

In its effort to rival GSK’s shingles vaccine Shingrix, Curevo Vaccine has circled up $110 million and recruited two former ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Researchers at the University of Cologne and University Hospital Cologne have determined that the novel mRNA-based COVID-19 ...